Hemoglobin Drop
at the bedside
- assess hemodynamic stability first
- review Hb trend, rate of fall against baseline
- repeat CBC if result unexpected
- check sample: drip-arm or wrong-tube draw is a common false alarm
- two large-bore cannulas + group and crossmatch if unstable or actively bleeding
escalate now if
- hypotension, tachycardia, poor perfusion
- chest pain or syncope
- visible active bleeding
- Hb fall > 2 g/dL within 24 to 48 hr
- bleeding on an anticoagulant
focused check
HPI
- bleeding: melena, hematemesis, PR bleeding, hematuria, heavy menses, epistaxis
- hidden bleeding: abdominal/back/flank pain, thigh swelling, recent procedure/surgery, trauma/falls
- hemolysis: jaundice, dark urine
- background: CKD, liver disease, known anemia, hemoglobinopathy, recent transfusion
- meds: anticoagulants (which, last dose), antiplatelets, NSAIDs
examination
- general: pallor, jaundice, ecchymosis, purpura
- bleeding source: PR exam, Foley bag, drains, procedure/line sites, hematomas
- abdomen: tenderness, distension, organomegaly
- perfusion: BP trend + postural drop, capillary refill, urine output
send now
- initial: repeat CBC, renal function, LFTs, coagulation profile, group and crossmatch
- hemolysis screen: LDH, bilirubin, haptoglobin, reticulocytes, direct antiglobulin test, blood film
- bleeding: stool occult blood if no visible source; imaging by suspected site
- recently transfused → delayed hemolytic reaction (5–14 days): direct antiglobulin test
which of the four is it
- Hb fall plus shock: bleeding until proven otherwise.
- Hb fall plus jaundice: hemolysis until proven otherwise.
- Hb fall after large-volume fluids: consider dilution.
- Hb fall over weeks: chronic anemia workup, not a ward emergency.
- Exclude spurious sample before treating the number.
treat
unstable or actively bleeding
- crystalloid 500 to 1000 mL while assessing; blood is the resuscitation fluid in hemorrhage
- uncontrolled → activate massive hemorrhage protocol
- find and control the source; call the relevant specialty early
- hold the anticoagulant; reverse if bleeding is significant (below)
suspected upper GI bleed
- IV PPI 80 mg stat, then 8 mg/h infusion
- escalate for endoscopy within 24 hr, sooner if unstable
transfusion thresholds
- stable inpatient: transfuse below 7 g/dL
- cardiovascular disease: 8 g/dL
- acute MI: target ~10 g/dL now favored
- active bleeding: transfuse to the patient, not the number
- give one unit, then recheck (expect ~1 g/dL rise per unit); ask about previous reactions
why acute MI is the exception
- Restrictive rule (transfuse below 7 g/dL) from AABB 2023, applies to stable inpatients.
- MINT (2023), restrictive vs liberal transfusion in acute MI: primary outcome not significant, but cardiac death and later mortality favored liberal; pooled trial data pointed the same way.
- Current guidance: target ~10 g/dL in acute MI (weak, low-certainty recommendation); other cardiovascular disease stays at 8 g/dL.
- In an infarcting patient, do not sit on Hb 8.5 without asking cardiology.
reversing the anticoagulant
- warfarin: 4F-PCC 25–50 units/kg by INR + IV vitamin K 10 mg IV; preferred over FFP.
- dabigatran: idarucizumab 5 g IV.
- apixaban, rivaroxaban, edoxaban: 4F-PCC 25–50 units/kg (andexanet alfa withdrawn from US market Dec 2025; availability varies, ask hematology + follow local protocol).
- heparin: protamine; antiplatelets: platelet transfusion not routinely helpful, needs specialist decision.
- Reversal is a senior decision: thrombotic cost is real.
no active bleeding
- monitor trend, investigate occult bleeding and hemolysis
- review drugs that suppress marrow or cause hemolysis
calculator Glasgow-Blatchford (GI bleed) · MDCalc ↗︎
recheck
- after transfusion: recheck Hb (expect ~1 g/dL rise per unit)
- after active-bleeding intervention: reassess perfusion, repeat Hb by trend, not fixed interval
- no active bleeding: trend Hb, repeat hemolysis/occult-bleeding workup if cause unclear
before leaving
- document: suspected cause, transfusion/reversal given (product, dose, time), response
- pending: repeat CBC, hemolysis screen, or source-directed imaging sent
- hand over: current trend, transfusion trigger, who to call if Hb falls further
if not improving / further escalation
- GI: hematemesis, melena, suspected variceal bleed → endoscopy
- surgery / IR: uncontrolled or inaccessible source, post-op bleed
- hematology: hemolysis, DIC, transfusion reaction, blood product refusal
- ICU: shock, massive transfusion, airway risk with hematemesis
MOC pearl
rapid Hb drop → think bleeding, hemolysis, dilution, or lab error. Iron deficiency almost never explains a sudden inpatient Hb fall.
evidence
| source | type |
|---|---|
| AABB 2023 restrictive-transfusion guideline | international guideline |
| MINT trial 2023 (acute MI transfusion threshold) | major peer-reviewed trial |
| DOAC-reversal agent availability, cross-checked 2025–2026 | regulatory / safety update |
Verify indication, dose, allergies, interactions, renal/hepatic function and local protocols before prescribing.
free the on-call checklist covers the whole shift on one printable page.
More clinical resources in the MOC+ Library →
reviewed Jul 2026updated Sep 2026file lab/cbc-hemoglobin-drop